Owned by Transnetyx Holding Corporation, Transnetyx, Inc., is a genetic testing company created to address the growing need of genetic researchers to test, or genotype, the DNA of genetically altered laboratory mice. Our proprietary technology and unique business model allow us to perform rudimentary, but essential test faster, more accurately, and at lower cost than laboratory technicians can perform on their own.

In late 2009, Transnetyx Holding Corp. launched its plan to address the high growth segment of human testing for specific pharmacogenomic applications. Under the division name Harmonyx Diagnostics, the company reconfigured its laboratory processes and operations for CLIA testing applications. Initially the company will be applying its process to the compounds Plavix (Clopidogrel) and Warfarin (Coumadin) and will be watching for market adoption of other pharmacogenomic panels of high throughput use.

Transnetyx and Harmonyx are both qualified to provide fast, accurate, and cost effective testing services due to our robust experience in business process development, laboratory automation, and high throughput genetic testing.

Because this our singular focus Transnetyx Holding Corp. is dedicated in providing world class service and becoming the industry leader in automated genetic testing.